Found: 1
Select item for more details and to access through your institution.
No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.
- Published in:
- Leukemia (08876924), 2003, v. 17, n. 9, p. 1827, doi. 10.1038/sj.leu.2403035
- By:
- Publication type:
- Article